Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Hemispherx_Biopharma> ?p ?o. }
Showing items 1 to 30 of
30
with 100 items per page.
- Hemispherx_Biopharma abstract "Hemispherx Biopharma (NYSE MKT: HEB) is a biopharmaceutical company based in Philadelphia, Pennsylvania. Founded in 1990, the company has 32 employees.The company has created an immunomodulatory double stranded RNA drug called Ampligen. The company is developing Ampligen to use as a treatment for chronic fatigue syndrome.On April 3, 2001, Hemispherx Biopharma, Inc. adjusted and restated its 1999 financial statements to reflect a charge relating to an extension of the exercise period to certain warrants as of February 1999. On April 3, 2006, Hemispherx Biopharma, Inc. restated financial results for 2003 and 2004 due to accounting mistakes related to debentures and warrants issued between March 2003 and August 2005.".
- Hemispherx_Biopharma wikiPageExternalLink www.hemispherx.net.
- Hemispherx_Biopharma wikiPageID "9519252".
- Hemispherx_Biopharma wikiPageRevisionID "571919553".
- Hemispherx_Biopharma hasPhotoCollection Hemispherx_Biopharma.
- Hemispherx_Biopharma subject Category:Biopharmaceuticals.
- Hemispherx_Biopharma subject Category:Companies_based_in_Philadelphia,_Pennsylvania.
- Hemispherx_Biopharma subject Category:Companies_established_in_1990.
- Hemispherx_Biopharma subject Category:Companies_listed_on_the_American_Stock_Exchange.
- Hemispherx_Biopharma type Abstraction100002137.
- Hemispherx_Biopharma type CompaniesBasedInPhiladelphia,Pennsylvania.
- Hemispherx_Biopharma type CompaniesEstablishedIn1990.
- Hemispherx_Biopharma type CompaniesListedOnTheNewYorkStockExchange.
- Hemispherx_Biopharma type Company108058098.
- Hemispherx_Biopharma type Group100031264.
- Hemispherx_Biopharma type Institution108053576.
- Hemispherx_Biopharma type Organization108008335.
- Hemispherx_Biopharma type SocialGroup107950920.
- Hemispherx_Biopharma type YagoLegalActor.
- Hemispherx_Biopharma type YagoLegalActorGeo.
- Hemispherx_Biopharma type YagoPermanentlyLocatedEntity.
- Hemispherx_Biopharma comment "Hemispherx Biopharma (NYSE MKT: HEB) is a biopharmaceutical company based in Philadelphia, Pennsylvania. Founded in 1990, the company has 32 employees.The company has created an immunomodulatory double stranded RNA drug called Ampligen. The company is developing Ampligen to use as a treatment for chronic fatigue syndrome.On April 3, 2001, Hemispherx Biopharma, Inc.".
- Hemispherx_Biopharma label "Hemispherx Biopharma".
- Hemispherx_Biopharma sameAs m.03p2b0n.
- Hemispherx_Biopharma sameAs Q5712100.
- Hemispherx_Biopharma sameAs Q5712100.
- Hemispherx_Biopharma sameAs Hemispherx_Biopharma.
- Hemispherx_Biopharma wasDerivedFrom Hemispherx_Biopharma?oldid=571919553.
- Hemispherx_Biopharma homepage www.hemispherx.net.
- Hemispherx_Biopharma isPrimaryTopicOf Hemispherx_Biopharma.